AR217615A1 - Procedimiento para obtener una vacuna para prevencion de la prenez - Google Patents

Procedimiento para obtener una vacuna para prevencion de la prenez

Info

Publication number
AR217615A1
AR217615A1 AR258670A AR25867075A AR217615A1 AR 217615 A1 AR217615 A1 AR 217615A1 AR 258670 A AR258670 A AR 258670A AR 25867075 A AR25867075 A AR 25867075A AR 217615 A1 AR217615 A1 AR 217615A1
Authority
AR
Argentina
Prior art keywords
pregnancy
vaccine
prevention
procedure
obtaining
Prior art date
Application number
AR258670A
Other languages
English (en)
Spanish (es)
Original Assignee
All India Inst Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Inst Med filed Critical All India Inst Med
Application granted granted Critical
Publication of AR217615A1 publication Critical patent/AR217615A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
AR258670A 1975-01-28 1975-05-07 Procedimiento para obtener una vacuna para prevencion de la prenez AR217615A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54467775A 1975-01-28 1975-01-28

Publications (1)

Publication Number Publication Date
AR217615A1 true AR217615A1 (es) 1980-04-15

Family

ID=24173127

Family Applications (1)

Application Number Title Priority Date Filing Date
AR258670A AR217615A1 (es) 1975-01-28 1975-05-07 Procedimiento para obtener una vacuna para prevencion de la prenez

Country Status (11)

Country Link
US (1) US4161519A (cs)
AR (1) AR217615A1 (cs)
CA (1) CA1054937A (cs)
CH (1) CH614626A5 (cs)
DE (1) DE2518546A1 (cs)
DK (1) DK145283C (cs)
FI (1) FI54997C (cs)
IL (1) IL47177A (cs)
NL (1) NL7505412A (cs)
NO (1) NO145083C (cs)
SE (2) SE432526B (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
US4691006A (en) * 1983-03-04 1987-09-01 Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
US6143305A (en) * 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US5006334A (en) * 1973-05-07 1991-04-09 The Ohio State University Antigenic modification of polypeptides
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4767842A (en) * 1973-05-07 1988-08-30 The Ohio State University Antigenic modification of polypeptides
US4762913A (en) * 1973-05-07 1988-08-09 The Ohio State University Antigenic modification of polypeptides
US6039948A (en) * 1973-05-07 2000-03-21 The Ohio State University Method for treatment of antigenically modified polypeptides
US5698201A (en) * 1973-05-07 1997-12-16 The Ohio State University Method for treatment of antigenically modified polypeptides
US6096318A (en) * 1973-05-07 2000-08-01 The Ohio State University Antigenically modified HCG polypeptides
US4313871A (en) * 1978-02-06 1982-02-02 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4268435A (en) * 1979-02-06 1981-05-19 Research Corporation Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4966888A (en) * 1985-07-08 1990-10-30 Cornell Research Foundation, Inc. hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine
US4556555A (en) * 1985-01-25 1985-12-03 North Carolina State University Process for the immunological neutering of animals
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5817753A (en) * 1985-12-04 1998-10-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
US4855285A (en) * 1985-12-04 1989-08-08 The Ohio State University Research Foundation Antigenic modification of polypeptides
US5762931A (en) * 1992-12-31 1998-06-09 National Institute Of Immunology Anti-cancer utility of HCG vaccines
WO1996015807A1 (en) * 1994-11-21 1996-05-30 Scofield Virginia L Sperm as vaccine vectors
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6716428B1 (en) 1999-10-06 2004-04-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
IL161708A0 (en) * 2001-11-16 2004-09-27 Pharmexa As Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
US20030185845A1 (en) * 2001-11-16 2003-10-02 Steen Klysner Novel immunogenic mimetics of multimer proteins
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
US8119117B2 (en) 2002-11-12 2012-02-21 Vaxum, Llc Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity
WO2004099244A2 (en) 2003-05-09 2004-11-18 Pharmexa A/S Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
WO2005051991A2 (en) 2003-11-24 2005-06-09 Sidney Kimmel Cancer Center Mucin antigen vaccine
US8828957B2 (en) * 2003-12-11 2014-09-09 Microvax, Llc Methods for generating immunity to antigen
US20060286074A1 (en) * 2005-05-31 2006-12-21 Yucheng Tang Methods for immunotherapy of cancer
US9533036B2 (en) * 2005-11-07 2017-01-03 Microvax, Llc Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622426A5 (en) * 1973-05-07 1981-04-15 Univ Ohio Contraceptive composition

Also Published As

Publication number Publication date
SE7505411L (sv) 1976-07-29
DK145283C (da) 1983-05-16
NO145083C (no) 1982-01-27
US4161519A (en) 1979-07-17
FI54997C (fi) 1979-05-10
IL47177A (en) 1979-01-31
SE432526B (sv) 1984-04-09
NO145083B (no) 1981-10-05
CA1054937A (en) 1979-05-22
SE7807571L (sv) 1978-07-05
CH614626A5 (cs) 1979-12-14
DK145283B (da) 1982-10-25
DK206975A (da) 1976-07-29
FI54997B (fi) 1979-01-31
SE432706B (sv) 1984-04-16
DE2518546A1 (de) 1976-07-29
NL7505412A (nl) 1976-07-30
IL47177A0 (en) 1975-06-25
NO751680L (cs) 1976-07-29
FI751746A7 (cs) 1976-07-29

Similar Documents

Publication Publication Date Title
AR217615A1 (es) Procedimiento para obtener una vacuna para prevencion de la prenez
AR222796A1 (es) Un procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
AR222624A1 (es) Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada
RO72997A (ro) Procedeu pentru prepararea benzoilureido-nitro-difenileteri
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
MX143488A (es) Procedimiento para la preparacion de resorcinas
MX3549E (es) Procedimiento mejorado para la conversion de una aldosa a cetosa
MX4906E (es) Procedimiento mejorado para la obtencion de una mezcla de esteres
AR210349A1 (es) Procedimiento para la preparacion de 6-coloro-2(piperacinil)piracina
MX4221E (es) Procedimiento para la preparacion de una vacuna contra la hidrofobia
MX143610A (es) Procedimiento para la obtencion de copolimeros de etilsulfonato-alquilamina
MX5599E (es) Procedimiento para la preparacion de una composicion farmaceutica a base de trihidrato de amoxicilina
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
AR210453A1 (es) Procedimiento para la preparacion de una 6-alfa-dioxitetraciclina
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR213175A1 (es) Procedimiento para preparar s-derivados de 3-amino-4-imino-rifamicina
MX3789E (es) Procedemiento para la preparacion de una aleacion dental
AR213275A1 (es) Metodo para la preparacion de una cinamamida
AR220361A1 (es) Procedimiento para la preparacion de una 2-benzazepina sustituida
MX3739E (es) Procedimiento para la preparacion de acilamino-penicilinas-6-substituida
ES451234A0 (es) Un procedimiento para la preparacion de una composicion de blanqueo.
AR221031A1 (es) Procedimiento para preparar un compuesto de benzoil-fenilindina y benzoil-fenilnaftaleno
MX146606A (es) Procedimiento mejorado para preparar la cubierta de una microcapsula